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ABSTRACT
Background: Food neophobia is considered a behavioral trait
closely linked to adverse eating patterns and reduced dietary quality,
which have been associated with increased risk of obesity and
noncommunicable diseases.
Objectives: In a cross-sectional and prospective study, we examined
how food neophobia is associated with dietary quality, health-related
biomarkers, and disease outcome incidence in Finnish and Estonian
adult populations.
Methods: The study was conducted based on subsamples of the
Finnish DIetary, Lifestyle, and Genetic determinants of Obesity
and Metabolic syndrome (DILGOM) cohort (n = 2982; age range:
25–74 y) and the Estonian Biobank cohort (n = 1109; age range:
18–83 y). The level of food neophobia was assessed using the Food
Neophobia Scale, dietary quality was evaluated using the Baltic Sea
Diet Score (BSDS), and biomarker profiles were determined using
an NMR metabolomics platform. Disease outcome information
was gathered from national health registries. Follow-up data on
the NMR-based metabolomic profiles and disease outcomes were
available in both populations.
Results: Food neophobia associated significantly (adjusted
P < 0.05) with health-related biomarkers [e.g., ω-3 (n–3) fatty
acids, citrate, α1-acid glycoprotein, HDL, and MUFA] in the
Finnish DILGOM cohort. The significant negative association
between the severity of food neophobia and ω-3 fatty acids
was replicated in all cross-sectional analyses in the Finnish
DILGOM and Estonian Biobank cohorts. Furthermore, food
neophobia was associated with reduced dietary quality (BSDS: β:
−0.03 ± 0.006; P = 8.04 × 10−5), increased fasting serum insulin
(β: 0.004 ± 0.0013; P = 5.83 × 10−3), and increased risk of type 2
diabetes during the ∼8-y follow-up (HR: 1.018 ± 0.007; P = 0.01)
in the DILGOM cohort.
Conclusions: In the Finnish and Estonian adult populations, food
neophobia was associated with adverse alteration of health-related
biomarkers and risk factors that have been associated with an
increased risk of noncommunicable diseases. We also found that
food neophobia associations with ω-3 fatty acids and associated
metabolites are mediated through dietary quality independent of
body weight. Am J Clin Nutr 2019;110:233–245.
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Introduction
Food neophobia is a behavioral trait in which a person desists
from tasting and experiencing unfamiliar or novel foods. Previous
studies have shown that food neophobia is a highly heritable
trait, with heritability estimates up to 78% (1). To this end, a
7-degree Food Neophobia Scale (FNS) questionnaire has been
developed for the reliable measurement of food neophobia (2).
Food neophobia is associated with several factors, including
age, gender, personality features, living area, education level,
and socioeconomic status (3–7). Furthermore, a high prevalence
of food neophobia has been detected in children in particular
and in people with low socioeconomic status living in rural
areas (8, 9). To some extent, food neophobia in children can be
considered a normal and developmentally appropriate response
characterized as “omnivore’s dilemma,” in which the sampling
of new food items may provide a source of nutrition or toxicity,
thus potentially resulting in neophobic behavior.
Food neophobia is also associated with the development of
other eating disorders and a reduced intake of fish and vegetables,
leading to reduced overall dietary quality (4, 9). Previously,
reduced dietary quality has been associated with an increased risk
of obesity and subsequent chronic diseases [e.g., cardiovascular
disease (CVD), coronary heart disease (CHD), and type 2
diabetes (T2D)] and inflammation (10–13). However, evidence
of the role played by individual food items in inflammation,
CVD, and T2D is still quite scarce and contradictory (14–
18). Food items such as fruit, vegetables, whole grains, fish,
and low-fat milk products are considered beneficial with regard
to reducing obesity-induced inflammation, CVD, and T2D,
whereas processed red meat and alcohol are considered risk
factors (14, 19–21). Contrary to individual food items, whole-
diet approaches based on dietary scores have achieved greater
success in assessing associations between dietary quality and
health-related risk factors (17, 22–24). In particular, scores based
on Dietary Approaches to Stop Hypertension, the Alternate
Healthy Eating index, and the Mediterranean diet have been well
acknowledged in predicting health outcomes (22, 25, 26).
Food neophobia and its association with dietary quality and
health both at the molecular level and at the disease outcome level
are still underresearched in adult populations (6, 9). The aim of
our study was to assess how food neophobia is associated with
dietary quality and health-related biomarkers by examining the
Baltic Sea Diet Score (BSDS) and NMR metabolomic profiles
of the Finnish adult population. Furthermore, we investigated
whether there is an association between food neophobia and
health-related adverse outcomes for CVD, CHD, and T2D. The
Estonian Biobank cohort was utilized to replicate findings from
the NMR-based metabolomics and disease outcomes. Better
understanding and recognition of behavioral eating disorders
and dietary quality could provide valid noninvasive tools for
the assessment and prediction of future risk for metabolic
comorbidities.
Methods
Study design
A cross-sectional design was adopted for the study in
order to investigate the association between food neophobia
and dietary quality, NMR-based metabolomic profiles, and
metabolic risk markers in Finnish and Estonian population-based
cohorts (Figure 1). Because follow-up NMR-based metabolomic
samples were available from subsamples of both cohorts, the
food neophobia association with the metabolomic profile was
also examined in a prospective manner (Figure 1). To determine
whether food neophobia association with themetabolomic profile
is mediated through dietary quality, we also investigated the
association between dietary quality and the metabolomic profile.
The food neophobia association with disease incidence was
also studied in a prospective manner because we had follow-
up information on CVD, CHD, and T2D disease incidence,
which was available in national health and death registries for
both cohorts. NMR-based metabolomic profiles were primary
outcome variables of the study, and dietary quality, metabolic
risk markers, and disease outcome incidence were secondary
variables.
Study populations and data collection
The research was conducted based on the DIetary, Lifestyle,
and Genetic determinants of Obesity and Metabolic syndrome
(DILGOM) 2007 study and the follow-up DILGOM 2014
study (27). The DILGOM 2007 study was a sub-cohort of the
National FINRISK 2007 study, a national health examination
study including questionnaires, measurements, and blood sample
collection. Both of the DILGOM studies were carried out by
the National Institute for Health and Welfare (THL) in Finland
(28). FINRISK studies were conducted every 5 y to monitor risk
factors for major noncommunicable diseases in a random sample
across 5 regions in Finland (29). The DILGOM study aimed to
observe more closely how diet, psychosocial factors, lifestyle,
environment, and genetics are linked to obesity and metabolic
syndrome. The baseline DILGOM 2007 study sample (n= 5024)
consisted of men and women aged 25–74 y. A total of 4581
participants were invited to participate in the DILGOM 2014
follow-up study, after excluding those who had since died, those
who had moved abroad, and those whose contact information
was no longer available (n = 443). All of the invited participants
received the study questionnaire by mail [participation: n= 3735
(82%)], which also included the FNS questions. The participants
from 2 original study areas (Helsinki and Turku) were also
invited for clinical examination and sampling [n = 1312 (74%)].
For study purposes, individuals from the DILGOM 2007 who
had completed the FNS questionnaire and for whom there were
data on NMR-based metabolomic profile and anthropometric
measurements (n= 2982) were included in the analytical sample
(Figure 1,Table 1). Follow-up clinical measurements and sample
information were available for a subsample of the selected
individuals (n = 1118) (Figure 1). The study protocol for the
DILGOM cohort was approved by the Coordinating Ethics
Committee of the Helsinki and Uusimaa Hospital District. The
participants gave written informed consent in accordance with
the Declaration of Helsinki.
The Estonian Biobank cohort was utilized as a replication
study sample for food neophobia associations with NMR-
based metabolomic profiles and disease outcomes. The main
objective of the Estonian Biobank study was to investigate the
environmental, genetic, and behavioral background of common
diseases and traits in the Estonian population (30). The cohort
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was a volunteer-based sample of the Estonian adult population
(n = 52,000) recruited from throughout Estonia in 2002–
2010. The existing data were collected by means of health
examinations and questionnaires regarding lifestyle, diet, and
clinical diagnoses. The data used for the study were collected
during initial recruitment (2002–2010) and during the follow-up
examination (2011–2013), from which individuals with relevant
information (first examination, n = 1109; second examination,
n = 953) were included in the study (Figure 1, Table 1). DNA,
white blood cells, and blood plasma were extracted from the
obtained blood samples. For a subset of the Estonian Biobank
cohort, NMR-basedmetabolomic profilingwas conducted at both
the first and the second examination (Figure 1). The Estonian
Biobank study was approved by the Ethics Review Committee
on Human Research of the University of Tartu and the Estonian
Genome Center, University of Tartu scientific committee.
Written informed consent was obtained from participants in
accordance with the Declaration of Helsinki.
Measurement of food neophobia
We used a validated 7-degree FNS for the reliable mea-
surement of food neophobia (Supplemental Table 1) (2). The
questionnaire included 10 statements (e.g., “I am constantly
sampling new and different foods”) that respondents rated on
a scale from 1 (strongly agree) to 7 (strongly disagree). The
severity of food neophobia was calculated as the total score for
all questions. The FNS ranged from 10 to 70, where higher
scores indicate a greater level of food neophobia. Some of
the questions were reverse scored compared with the original
phrasing, which was taken into account when calculating the total
scores. No official distinctive thresholds or cutoff values have
been determined to specify food neophobia. However, the total
FNS scores can be artificially divided into 3 groups based on
the existing literature: food neophilics (10–24), median group
(25–39), and food neophobics (40–70). These were used in our
study for categorization, if needed (8). Although it has been
demonstrated that excluding 2 or 4 items from the FNS can
improve the method when used in some countries, including
Finland (31), we decided to use the original 10-point FNS scale
to ensure comparability between the investigated Finnish and
Estonian cohorts. No previous data exist on the efficacy of the
reduced FNS in the Estonian population. For both populations,
FNS was measured only once, during the second study visits
for 1) DILGOM 2014 and 2) the Estonian Biobank cohort
2010–2012. Food neophobia is considered a relatively stable
trait during adulthood (4), which is why we justified the use
of singular measured FNS scores for the baseline, follow-up,
and longitudinal analyses in our analytical sample consisting
of adults. The majority of the existing literature demonstrates
that the level of food neophobia varies during childhood and
adolescence, not adulthood (4). However, note that some studies
FIGURE 1 Flowchart of the study design and participant selection. The study consisted of 1) cross-sectional and longitudinal analysis of food neophobia
association with health-related biomarkers measured with an NMR-based metabolomics platform and 2) longitudinal analysis of the association of food
neophobia with chronic disease (e.g., CHD, CVD, and T2D) incidence in the Finnish DILGOM (n = 2982) and Estonian Biobank cohorts (n = 1109).
Food neophobia association with dietary quality and metabolic risk markers was also studied cross-sectionally in the Finnish DILGOM cohort. Inclusion and
exclusion criteria for sample size determination are shown. CHD, coronary heart disease; CVD, cardiovascular disease; DILGOM, DIetary, Lifestyle, and
Genetic determinants of Obesity and Metabolic syndrome study; FNS, Food Neophobia Scale; T2D, type 2 diabetes.
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TABLE 1 Study population baseline characteristics categorized by the level of food neophobia1
DILGOM 2007 cohort Estonian Biobank cohort, first examination
Food
neophilics Median group
Food
neophobics Total
Food
neophilics Median group
Food
neophobics Total
Sample size, n (%) 891 (29.9) 1217 (40.8) 874 (29.3) 2982 (100) 258 (23.3) 591 (53.3) 260 (23.4) 1109 (100)
Gender
Men, n (%) 406 (45.6) 549 (45.1) 418 (47.8) 1373 (46) 127 (49.2) 289 (48.9) 124 (47.7) 540 (48.7)
Women, n (%) 485 (54.4) 668 (54.9) 456 (52.2) 1609 (54) 131 (50.8) 302 (51.1) 136 (52.3) 569 (51.3)
Age, y 48 ± 12.3 53.1 ± 12.5 57.1 ± 11.7 52.7 ± 12.7 41.4 ± 14.5 50.3 ± 15.2 55.4 ± 14.6 49.4 ± 15.6
BMI, kg/m2 26.1 ± 4.4 26.6 ± 4.7 26.8 ± 4.6 26.5 ± 4.6 26.3 ± 4.7 27 ± 4.9 28.2 ± 5.3 27.1 ± 5
Education level
Low, n (%) 162 (18.3) 316 (26.1) 324 (37.2) 802 (27.0) 19 (7.4) 63 (10.7) 55 (21.1) 137 (12.4)
Median, n (%) 271 (30.7) 446 (36.8) 313 (35.9) 1030 (34.7) 122 (47.5) 349 (59.0) 151 (58.1) 622 (56.1)
High n (%) 451 (51.0) 450 (37.1) 234 (26.9) 1135 (38.3) 116 (45.1) 179 (30.3) 54 (20.8) 349 (31.5)
Living region
Urban, n (%) 442 (49.6) 510 (41.9) 305 (34.9) 1257 (42.2) 155 (60.1) 321 (54.3) 118 (45.4) 594 (53.6)
Rural, n (%) 449 (50.4) 707 (58.1) 569 (65.1) 1725 (57.8) 103 (39.9) 270 (45.7) 142 (54.6) 515 (46.4)
FNS 18.2 ± 4.0 31.9 ± 4.3 47.6 ± 6.9 32.4 ± 12.4 19.1 ± 3.9 32.1 ± 4.3 45.5 ± 5.2 32.2 ± 10.1
1Excluding FNS, which was gathered during the second study visits. Values are means ± SDs for age, BMI, and FNS. Sample size, gender, education
level, and living region are depicted as frequency (cumulative percentage). For the Finnish DILGOM 2007 cohort, regions were defined as follows: urban
(Helsinki, Vantaa, Turku, and Loimaa) and rural (North Karelia, Northern Savo, and Oulu). Education level was defined in the Estonian Biobank cohort as
follows: low, below secondary education; median, secondary education; and high, higher education. For the Finnish DILGOM cohort, education levels were
defined by dividing individuals into thirds based on number of years of education. DILGOM, DIetary, Lifestyle, and Genetic determinants of Obesity and
Metabolic syndrome study; FNS, Food Neophobia Scale.
have detected increased levels of food neophobia in the elderly
population aged 66–80 y (3).
Determination of dietary quality in the DILGOM cohort
Dietary information was available in the DILGOM studies
from a validated 131-item FFQ, designed to assess habitual diet
during the preceding 12 mo, calculated by using the national food
composition database (Fineli) and in-house software (Finessi)
(32). An FFQ-based BSDS was applied for dietary quality
assessment because locally tailored diets are needed to effectively
measure the associations between a healthy diet and health
outcomes in other populations, such as Scandinavians. Dietary
scores such as the BSDS have the advantage of taking into
account the complex interactions and cumulative effects of
multiple foods and nutrients within the diet compared with
the information from individual food items (32). The BSDS
has been proven to predict overall dietary quality in the
Finnish population and is a valid tool for assessing diet–disease
relations (32). Previously, the BSDS has been examined in
relation to lower abdominal obesity and lower weight gain
(27), cardiometabolic risk factors, obesity-related markers of
inflammation, and diabetes (11–13, 33).
In total, 9 components are included in the BSDS (Table 2).
BSDS components are scored on a scale from 0 to 3, apart
from alcohol, which is scaled from 0 to 1. Overall dietary
quality can be assessed by calculating the total sum score
of the BSDS categories, which ranges between 0 and 25. It
is noteworthy that for some categories, the scoring method
is negative, which has to be accounted for. Higher scores
for the BSDS are indicative of higher dietary quality. FFQ-
based dietary information for BSDS calculation was gathered
during the DILGOM 2007 and the DILGOM 2014 follow-up.
In addition, specific FFQ-based dietary component information
(e.g., energy intake, protein intake, carbohydrate intake, and fat
intake) from both data collections was utilized to further assess
food neophobia association with dietary quality factors. No
comparable dietary information was available from the Estonian
Biobank cohort.
Metabolomic data preparation and management
A high-throughput NMR metabolomics platform was used
for the quantification of blood lipids and metabolic measures
in both study populations (34, 35). The full process and
methods of sample preparation and quantification utilized in this
study are described in detail elsewhere (34, 35). Briefly, the
samples were measured using a Bruker AVANCE III HD NMR
500-MHz spectrometer equipped with a cryogenically cooled
TCI CryoProbe Prodigy (34, 35). For the protocol, the used
measurement temperature was set to 36.95 degrees Celsius. A
wide distribution of different lipoprotein subclasses (e.g., VLDL,
LDL, and HDL), fatty acids, and apolipoproteins and a broad
selection of small molecules, such as glycolysis precursors,
amino acids, and inflammation biomarkers, were included in
the metabolites quantified and analyzed (Supplemental Table
2). The selection included 14 lipoprotein subclasses that were
analyzed as part of the full metabolite profile. Furthermore, the
quantified lipoproteins were divided into subclasses according to
particle size. In total, samples from DILGOM 2007 (n = 2982)
and DILGOM 2014 (n = 1118) participants and 228 different
metabolites were extracted and quantified. In addition, samples
from Estonian Biobank cohort participants at baseline (n= 1109)
and during follow-up (n = 953), provided by the Estonian
Genome Center, and 225 metabolites were available for replica-
tion. The Estonian Biobank cohort samples were gathered during
the first study visit between 2002–2010 and during the follow-up
of 2010–2012.
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TABLE 2 BSDS components and scoring in the Finnish DILGOM cohort1
Score component Content Scoring Points range
Fruits and berries Apples, pears, and berries Positive2 0–3
Vegetables Tomatoes, cucumber, leafy vegetables, roots, cabbage, and peas Positive 0–3
Low-fat milk Low-fat and fat-free milk Positive 0–3
Cereals Rye, oats, and barley Positive 0–3
Fish Salmon and freshwater fish Positive 0–3
Meat products Beef, pork, processed meat products, and sausages Negative3 0–3
Total fat4 Total fat intake Negative 0–3
Fat ratio The ratio of PUFA to saturated fat and trans fatty acids Positive 0–3
Alcohol5 Ethanol intake Negative 0–1
1BSDS, Baltic Sea Diet Score; DILGOM, DIetary, Lifestyle, and Genetic determinants of Obesity and Metabolic syndrome study.
2Highest consumption third received the highest points.
3Lowest consumption quartile received the highest points.
4Total fat intake as percentage of energy intake.
5Moderate ethanol intake ≤ 20 g for men and ≤ 10 g for women received 1 point; otherwise, 0 points were given. Total BSDS ranges from 0 to 25,
where higher scores are indicative of healthier overall diet (37).
Assessment of metabolic risk factors and disease outcomes
Numerous quantified and determined measures were available
to assess cardiovascular and glucose metabolism comorbidities.
Concentrations of high-sensitivity C-reactive protein (hs-CRP),
glycated hemoglobin (HbA1c), glucose, and insulin were deter-
mined from fasting (> 8h) venous blood samples in the central
laboratory of THL. In addition, anthropometric measures, BMI
(in kg/m2), and waist circumference, used for metabolic risk
status assessment, were determined. Waist circumference was
measured midway between the lower rib margin and iliac crest,
with rounding to the nearest 0.5 cm. Metabolic risk factors,
biomarkers, and anthropometric measures were obtained from
the Finnish DILGOM 2007 and follow-up DILGOM 2014
studies. Only BMI was available from the metabolic risk factor
information from the Estonian Biobank cohort initial recruitment
(2002–2010).
Disease outcomes (prevalences and incidences) and specific
diagnostic criteria for CVD, CHD, and T2D were collected
from national health registries to assess possible risks associated
with food neophobia in relation to disease outcomes in both
populations (Supplemental Methods) (32). The primary end-
points for disease outcomes in this study were newly diagnosed
CVD, CHD, and T2D during follow-up. Disease outcomes were
collected from 1) the Finnish hospital discharge register for
nonfatal outcomes and the causes of death register for fatal
outcomes and 2) the Estonian health and death registries. In
both populations, disease outcomes were linked and followed
for each participant using a personal identification number given
to every permanent resident. The International Classification of
Diseases (http://www.who.int/classifications/icd/en/) was used to
identify disease outcomes (Supplemental Methods). The Finnish
and Estonian cohorts were followed until December 31, 2015, so
that the average follow-up time was 8 y for disease outcomes in
both populations.
Statistical analysis
NMR metabolomic data skewness, normality, and outliers
were assessed with dot plots and histograms to ensure data
quality and reducibility of the results. Outliers were removed
based on an SD > 4 from the mean metabolite concentration.
A scaled logarithmic transformation was applied to normalize
metabolite variable distributions in all of the metabolomic
analyses. In addition, pregnant individuals were excluded from
all metabolomic analyses (Figure 1).
Linear regression was used to assess relations between the
level of food neophobia and metabolome biomarker concen-
trations in a cross-sectional study design in both baseline
and follow-up data sets of DILGOM and Estonian Biobank
cohorts. In addition, longitudinal analyses of these cohorts
were performed to evaluate changes occurring in metabolite
concentration in relation to the level of food neophobia. Smoking
status, BMI, age, gender, education level, diabetes status, fasting
time, and living region were taken into account as possible
confounding factors in the cross-sectional metabolomic analyses.
In the longitudinal metabolomic analyses, we accounted for
metabolite baseline concentration, age at baseline, BMI change
during follow-up, smoking status, gender, and education level at
the baseline. Similar analyses were conducted on the replication
material gathered from the Estonian Biobank cohort.
Linear regression was also used to assess the association
between dietary quality (BSDS) and NMR platform metabolites
to detect whether dietary quality mediates the association of
food neophobia on metabolic measures in the DILGOM cohort.
Mediation analysis was further complemented by 1) assessing
the association between FNS and BSDS and 2) applying the
BSDS as a covariate in the aforementioned food neophobia
metabolomic analyses. Metabolomic analyses were adjusted
in a similar manner as mentioned previously for the cross-
sectional metabolomic analyses assessing the association of food
neophobia. Analysis of BSDS association with food neophobia
was adjusted for education level, age, gender, BMI, and living
region.
The association of food neophobia with metabolic risk
factors (hs-CRP, HbA1c, fasting serum insulin and glucose,
BMI, and waist circumference) was also assessed with linear
regression; analyses were adjusted for smoking status, BMI, age,
gender, education level, and living region. Scaled logarithmic
transformation was applied for risk biomarkers but not for the
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anthropometric measures. Moreover, BMI was excluded as a
covariate from the anthropometric measure analyses due to
high intercorrelation with waist circumference. Individuals with
prevalent CVD, CHD, or T2D disease outcomes were excluded
from the data before analysis as possible confounding factors.
We used the Cox proportional hazards regression model to
investigate whether the severity of food neophobia was associated
with the future incidence of diseases during the follow-up time
of ∼8 y in the Finnish and Estonian populations. CHD, CVD,
and T2D prevalences and incidences were coded in a binomial
manner in the data set used for statistical analysis. The analyses
were adjusted for baseline age, baseline BMI, baseline education
level, and smoking status. Proportional hazard assumption tests
were conducted to ensure model validity. Individuals with
prevalent CVD, CHD, or T2D outcomes were excluded from the
disease outcome analyses (Figure 1).
In all the analyses, individuals with missing data were
excluded, and only individuals with complete information on the
necessary variables were included. Many of the same subclass
metabolites highly correlate with each other, as was detected
by principal component (PC) analysis, which showed a total of
24 PCs explaining > 95% of the variation seen in the data set.
The multiple-testing corrected significance level in the highly
correlated data was set accordingly (P < 0.05/24 PCs; i.e.,
P < 0.0021) in all analyses regarding NMR metabolomics.
R statistical software was used for all the statistical analyses
(version 3.3.3 or higher).
Results
The association of food neophobia with NMR-based
metabolomic profiles in the Finnish DILGOM
population-based cohort
Overall, individuals with higher levels of food neophobia
exhibited adverse metabolomic profiles compared with food
neophilics (Figure 2). In the cross-sectional analysis of DILGOM
2007, we observed an inverse association between the level of
food neophobia and several metabolite concentrations and their
ratios, such as 1) the ratio of ω-3 fatty acids to total fatty
acids (β: −0.006 ± 0.002; adjusted P = 3.47 × 10−3), 2)
cholesterol esters in very large HDL cholesterol particles (β:
−0.005 ± 0.001; adjusted P = 0.01), 3) total cholesterol in very
large HDL cholesterol particles (β: −0.005 ± 0.001; adjusted
P = 0.02), and 4) the concentration of very large HDL particles
(β: −0.004 ± 0.001; adjusted P = 0.05). In contrast, a positive
association was found for 1) the ratio ofMUFA to total fatty acids
(β: 0.005 ± 0.002; adjusted P = 0.05), 2) α1-acid glycoprotein
(β: 0.006 ± 0.001; adjusted P = 2.50 × 10−3), and 3) citrate
(β: 0.008 ± 0.002; adjusted P = 5.44 × 10−6) (Figure 3,
Supplemental Table 3).
These findings were further supported by the cross-sectional
analyses of the DILGOM 2014 cohort, in which food neophobia
associated similarly with the ratio of ω-3 fatty acids to total
fatty acids (β: −0.009 ± 0.003; adjusted P = 0.04) and α1-
acid glycoprotein (β: 0.008 ± 0.003; adjusted P = 0.06)
(Supplemental Table 4). In the DILGOM 2014 cohort, the most
significant association was found for the ratio of 22:6 DHA
to total fatty acids (β: −0.01 ± 0.003; adjusted P = 0.02)—a
metabolite belonging to the group of ω-3 fatty acids. Overall,
in both DILGOM 2007 and DILGOM 2014, a higher level of
food neophobia was associated with negative cardiometabolic
outcomes on lipid metabolites (e.g., decreases in ω-3 fatty acids
and very large HDL fractions and an increase in MUFAs) and
inflammation-related biomarkers (e.g., an increase in α1-acid
glycoprotein), whereas lower levels of food neophobia predicted
the opposite—more favorable concentrations of health-related
biomarkers (Figure 2, Supplemental Tables 3 and 4).
Finally, we used the data from both studies to conduct
a longitudinal analysis to explore whether the level of food
neophobia associated with serummetabolome profile modulation
during the 8-y follow-up (Supplemental Table 5). The findings
from cross-sectional analyses on ω-3 fatty acids were further cor-
roborated because food neophobia associated most significantly
with changes in metabolites associated with ω-3 fatty acids, such
as the ratio of 22:6 DHA to total fatty acids (β:−0.003± 0.0009;
adjusted P = 0.02) (Supplemental Table 5).
Replication: The association of food neophobia with
NMR-based metabolomic profiles in the Estonian Biobank
cohort
Cross-sectional analysis of the Estonian Biobank cohort first
examination samples replicated the inverse association between
the severity of food neophobia and ω-3 associated metabolites
(Supplemental Table 6). Significant findings were detected
for 1) the ratio of ω-3 fatty acids to total fatty acids (β:
−0.013 ± 0.003; adjusted P = 1.10 × 10−3), 2) the level of ω-3
fatty acids (β: −0.011 ± 0.003; adjusted P = 3.28 × 10−3), 3)
the ratio of 22:6 DHA to total fatty acids (β: −0.014 ± 0.003;
adjusted P = 4.05 × 10−4), and 4) the level of 22:6 DHA
(β: −0.012 ± 0.003; P = 0.01; adjusted P = 8.98 × 10−4)
(Supplemental Table 6). These findings were confirmed by
the cross-sectional analysis on the second time point samples,
where 1) the ratio of ω-3 fatty acids to total fatty acids (β:
−0.011 ± 0.003; adjusted P = 9.59 × 10−3), 2) the level of ω-3
fatty acids (β:−0.01± 0.003; adjustedP= 0.05), and 3) the ratio
of 22:6 DHA to total fatty acids (β: −0.011 ± 0.003; adjusted
P= 0.04) were also significantly associated with the level of food
neophobia (Supplemental Table 7). No significant association
was found in the longitudinal analysis of the Estonian Biobank
cohort, although cholesterol esters in very large HDL cholesterol
and total cholesterol in very large HDL cholesterol reached
nominal (P < 0.05) significance (Supplemental Table 8).
Overall, similar to observations in the Finnish population, levels
of food neophobia were associated with a similar modulation
of the metabolomic profile in the Estonian Biobank cohort,
especially regarding ω-3 fatty acids (Figure 4, Supplemental
Table 9).
Food neophobia associates with poorer dietary quality in the
DILGOM cohort
Food neophobia associates with reduced dietary quality, as
we found an inverse significant (P < 0.05) association between
FNS and BSDS in the DILGOM 2007 (Table 3) and DILGOM
2014 studies (Supplemental Table 10). This was confirmed
by observed significant (P < 0.05) differences in several
nutrient intakes between different levels of food neophobia in
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FIGURE 2 Overall differences in the metabolomic profile between different groups of food neophobia in the Finnish DILGOM cohort. Overall levels of
NMR-based metabolomics of the Finnish DILGOM 2007 cohort (n = 2982) were set as reference values to which food neophobics (FNS 40–70) in panel A
and food neophilics (FNS 10–24) in panel B were compared. The median group (FNS 25–39) compared to the reference level is depicted in Supplemental
Figure 1. For plotting, 150 health-related biomarkers were selected to demonstrate the overall differences in metabolomic profile between different levels
of food neophobia. Depicted polar plots are derived from metabolite raw values, where outliers based on 4 SD from the mean have been excluded. Plotted
metabolite values are represented as an SD change from the set reference z score. The red color indicates an increase and the blue a decrease compared with
the reference z score. The height of the bars depicts the z score level, and the scale is plotted on the figure apex vertically. Metabolites are ordered according
to subclass and z score values. Overall, more adverse trends in the metabolomic profile are detected in a linear fashion going from food neophilics to food
neophobics. ∗Significant difference between food neophobia groups, P < 0.05. Significant differences were calculated from an unadjusted linear regression
model. DILGOM, DIetary, Lifestyle, and Genetic determinants of Obesity and Metabolic syndrome study; FNS, Food Neophobia Scale.
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FIGURE 3 Food neophobia association with metabolite concentrations in the Finnish DILGOM 2007 cohort. The figure depicts alteration of metabolites
at different levels of food neophobia in the Finnish DILGOM 2007 cohort (n = 2982). For plotting, we selected metabolites that most significantly (adjusted
P < 0.05) associated with the level of food neophobia at baseline of both the DILGOM cohort and the Estonian Biobank cohort. The FNS score is represented
on the x axis ranging from 10 to 70, where higher scores indicate a higher level of food neophobia. Metabolite concentration is depicted on the y axis. The
gray hue around the plotted lines represents SE variation from the curve. DILGOM, DIetary, Lifestyle, and Genetic determinants of Obesity and Metabolic
syndrome study; FNS, Food Neophobia Scale.
both of the DILGOM studies (Table 3, Supplemental Table
10). Our significant findings on the ω-3 fatty acids in the
metabolomic analyses were further supported by higher intakes
of PUFAs in food neophilics (Table 3). Food neophilia was
also associated with some healthier aspects of diet, such as
higher intake of MUFAs, fiber, and protein. Individuals with
food neophilia also consumed lower amounts of saturated
fatty acids, carbohydrates, and salt. In contrast, alcohol was
least consumed by individuals with a higher level of food
neophobia.
Poorer dietary quality mediates food neophobia association
with serum metabolome profile
The BSDS was significantly associated with a group of
the same metabolites (e.g., ω-3 fatty acids, DHA, PUFA,
and MUFA; degree of unsaturation) as the FNS score in the
DILGOM 2007 cohort (Figure 5, Supplemental Table 11)
and the DILGOM 2014 cohort (Supplemental Table 12) after
accounting for detected associations in both the DILGOM and
Estonian Biobank cohorts. Furthermore, we found that BSDS
was more strongly associated (adjusted P < 10−6) with the
aforementioned metabolite concentrations compared with the
FNS score in the DILGOM 2007 cohort (Supplemental Table
11) and the DILGOM 2014 cohort (Supplemental Table 12).
The observed metabolite findings and significant association
between BSDS and FNS suggest that the association of food
neophobia with metabolite profiles (e.g., ω-3 fatty acids) is
partially mediated through differences in dietary quality. We
tested this further by accounting for BSDS in the model when
testing the FNS association with metabolite concentrations in
the DILGOM 2007 cohort (Supplemental Table 13) and the
DILGOM 2014 cohort (Supplemental Table 14). Adding BSDS
to the model diminished our significant association of FNS
with ω-3 fatty acids and MUFA concentrations (adjusted P >
0.05). In contrast, FNS association with α1-acid glycoprotein,
citrate, and HDL cholesterol metabolites persisted as significant,
thus implying that dietary quality might have a selective role
in mediating food neophobia association with certain serum
metabolites (Figure 5).
Association of food neophobia with metabolic risk factors
and disease outcomes
Food neophobia was not associated (P> 0.05) with waist cir-
cumference or BMI in the DILGOM 2007 cohort (Supplemental
Table 15) or the DILGOM 2014 cohort (Supplemental Table
16). Similarly, no significant association was found between
FNS and BMI in the Estonian Biobank cohort. However, of the
recognized metabolic risk factor biomarkers influencing the risk
of CVD, CHD, and T2D, the level of food neophobia associated
in the DILGOM 2007 cohort significantly with fasting serum
insulin concentration (β: 0.004 ± 0.013; P = 5.83 × 10–3)
but not with CRP and serum glucose concentrations (Supple-
mental Table 15). Similarly, in the DILGOM 2014 cohort, the
food neophobia association with serum insulin concentrations
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FIGURE 4 Food neophobia association with metabolite concentrations in the Estonian Biobank cohort first examination. The figure depicts alteration
of metabolites at different levels of food neophobia in the Estonian Biobank cohort (n = 1108). For plotting, we selected metabolites that most significantly
(adjusted P < 0.05) associated with the level of food neophobia at baseline of both the DILGOM cohort and the Estonian Biobank cohort. The FNS score is
represented on the x axis ranging from 10 to 70, where higher scores indicate a higher level of food neophobia. Metabolite concentration is depicted on the
y axis. The gray hue around the plotted lines represents SE variation from the curve. DILGOM, DIetary, Lifestyle, and Genetic determinants of Obesity and
Metabolic syndrome study; FNS, Food Neophobia Scale.
approached significance (β: 0.004 ± 0.002; P = 0.08). No
significant associations were found between food neophobia and
the other measured metabolic risk factors in the DILGOM 2014
cohort (Supplemental Table 16).
In addition, Cox regression analysis revealed that higher
levels of food neophobia predicted a higher incidence of newly
diagnosed T2D in the DILGOM cohort in the fully adjusted
model (HR: 1.018± 0.007;P= 0.01), thus supporting our finding
TABLE 3 Descriptive statistics of nutrition in the different groups of food neophobia in the DILGOM 2007 cohort
Descriptive statistics Linear regression statistics
Diet component Food neophilics Median group Food neophobics n1 Estimate (SE) P value
BSDS2,3 12.95 ± 4 13.21 ± 4.18 13.12 ± 4.24 869/1184/843 − 0.025 (0.006) 8.04 × 10−5
Energy, kJ 10,435.06 ± 3376 10,331.02 ± 3611 10,661.31 ± 3897 869/1184/843 5.74 (5.61) 3.06 × 10–1
Carbohydrates,3 E% 48.04 ± 5.91 49.08 ± 5.97 50.33 ± 6.29 869/1184/843 0.067 (0.009) 2.41 × 10−12
Protein,3 E% 17.92 ± 2.44 17.8 ± 2.45 17.31 ± 2.61 869/1184/843 − 0.028 (0.004) 1.06 × 10−11
Fat, E% 31.31 ± 4.76 30.91 ± 4.89 30.76 ± 5.05 869/1184/843 − 0.004 (0.008) 5.82 × 10−1
Fat, saturated,3 E% 11.4 ± 2.23 11.31 ± 2.39 11.65 ± 2.62 869/1184/843 0.016 (0.004) 2.40 × 10−5
Fat, monounsaturated,3 E% 11.2 ± 2.17 11 ± 2.19 10.83 ± 2.23 869/1184/843 − 0.007 (0.004) 4.60 × 10−2
Fat, polyunsaturated,3 E% 5.59 ± 1.17 5.52 ± 1.18 5.31 ± 1.12 869/1184/843 − 0.009 (0.002) 3.27 × 10−6
Fiber, g/MJ 2.95 ± 0.9 3.08 ± 0.96 3.11 ± 0.95 869/1184/843 − 0.002 (0.001) 1.63 × 10−1
Alcohol,3 E% 2.73 ± 3.07 2.2 ± 3.1 1.6 ± 2.88 869/1184/843 − 0.035 (0.005) 1.45 × 10−13
NaCl,3 g/MJ 0.92 ± 0.14 0.93 ± 0.14 0.92 ± 0.15 869/1184/843 − 0.001 (0.0002) 5.95 × 10−8
1Frequency (food neophilics/median group/food neophobics).
2Baltic Sea Diet Score.
3Significant association (P < 0.05) with food neophobia and diet components. Descriptive statistics are presented as mean (SD) unless otherwise noted.
Descriptive statistics are unadjusted for other factors. For BSDS and energy intake, regression model was adjusted for education level, age, gender, BMI, and
living region. For other measures, BMI was excluded from the regression model to avoid overcorrection. Linear regression model was used for all variables.
None of the nutrient variables were transformed for association estimation. The DILGOM 2014 follow-up dietary information is depicted in Supplemental
Table 10, where food neophobia associated significantly (P < 0.05) with all the same diet components. E%, energy percentage; kJ, kilojoule; g/MJ, grams per
megajoule.
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FIGURE 5 Food neophobia and dietary quality association with significant metabolite concentrations. The figure depicts the most significant metabolite
alteration in relation to the FNS and dietary quality as measured by the BSDS in the DILGOM 2007 cohort (n = 2935). For plotting, we selected metabolites
that most significantly (adjusted P< 0.05) associated with the level of food neophobia at baseline of both the DILGOM cohort and the Estonian Biobank cohort.
Separate curves present metabolite-level alteration in different BSDS categories. The BSDS categories used were 1) low dietary quality (0–8), 2) median dietary
quality (9–16), and 3) high dietary quality (17–24). Colors for the representative BSDS categories are as follows: red, low dietary quality; green, median dietary
quality; and blue, high dietary quality. The gray hue around the plotted lines represents SE variation from the curve. The figure particularly indicates that dietary
quality mediates food neophobia effects on ω-3 fatty acids and associated metabolites (e.g., DHA, degree of fatty acid unsaturation), whereas food neophobia
(and other related factors) mediates more directly differences in citrate, glycoprotein acetyls (mainly α1-acid glycoprotein), very large HDLs, and MUFAs.
BSDS, Baltic Sea Diet Score; DILGOM, DIetary, Lifestyle, and Genetic determinants of Obesity and Metabolic syndrome study; FNS, Food Neophobia Scale.
on the association between food neophobia and fasting serum
insulin concentrations (Table 4). In contrast, the level of food
neophobia did not associate with the incidence of CVD and CHD
in the DILGOM cohort. In the Estonian Biobank cohort, higher
levels of food neophobia predicted a higher incidence of CHD
(HR: 1.027 ± 0.011; P = 0.012), whereas no association with
CVD and T2D was detected (Table 4).
Discussion
This study is the first to comprehensively assess the association
of food neophobia with health-related biomarkers at the level of
the NMR-based metabolome. Food neophobia was significantly
associated with several health-related biomarkers, most strongly
with ω-3 fatty acids in both the Finnish DILGOM and Estonian
Biobank cohorts. In addition, food neophobia was associated
with poorer overall dietary quality in Finnish individuals
when measured by a score that illustrates healthy Nordic
diet and individual nutrient intake categories. Furthermore, a
high level of food neophobia was associated with an adverse
alteration of fasting serum insulin and an increased incidence
of T2D in the Finnish DILGOM cohort, whereas an increased
incidence of CHD was detected in the Estonian Biobank
cohort.
Several studies have shown that higher levels of food
neophobia associate strongly with reduced dietary quality in both
children (4, 36–38) and adults (1, 9, 39), thus suggesting that the
level of food neophobia relates significantly to eating behavior
and dietary quality throughout the whole life span. Our results
support these findings because we detected poorer dietary quality
in individuals with higher food neophobia when measured by
BSDS and specific dietary intake components. Furthermore, di-
etary quality is known to contribute to circulating concentrations
of health-related biomarkers, where dietary effects are mediated
mainly through the composition of daily food metabolome and
changes in body weight/composition (40–42). Previously, it has
been hypothesized that higher food neophobia along with adverse
dietary behavior and quality result in increased adiposity and
body weight. However, to date, contradictory findings have
been reported on a food neophobia association with adiposity
and body weight. These disparities in findings are most likely
due to differences in the study population age (9, 43). We did
not detect an association between adiposity measures and the
level of food neophobia in either the Finnish DILGOM or the
Estonian Biobank cohort, which suggests that our findings on
the metabolome might reflect the actual composition of the diet.
However, various factors, including physical activity, gender, and
genetics, also contribute to the alteration of the metabolomic
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TABLE 4 Statistics and results of Cox proportional hazards model on disease outcomes, T2D, CHD, CVD, in the Finnish DILGOM and Estonian Biobank
cohort1
Category Descriptive statistics of disease outcomes Cox proportional hazards model results
Disease Cohort n2 Prevalence Incidence Follow-up time, y n Coefficient HR (SE) z score P value
T2D DILGOM cohort 2982 207 140 8 2655 0.018 1.018 (0.007) 2.52 0.01
Estonian Biobank 1109 58 64 7.53 877 0.002 1.002 (0.016) 0.111 0.91
CHD DILGOM cohort 2982 74 115 8.28 2655 − 0.006 0.994 (0.009) − 0.7 0.48
Estonian Biobank 1109 191 114 7.21 877 0.027 1.027 (0.011) 2.504 0.01
CVD DILGOM cohort 2982 111 155 8 2655 0.001 0.99 (0.007) − 0.018 0.86
Estonian Biobank 1109 18 25 7.71 877 0.034 1.034 (0.03) 1.135 0.26
1For Cox proportional hazards regression analysis, individuals with past disease outcomes and missing data were excluded. Follow-up time is presented
as years for the whole study sample. Analysis was adjusted for baseline age, living region, gender, BMI, and smoking status in the DILGOM cohort. In the
Estonian Biobank cohort, baseline age, baseline BMI, smoking status, and lipid treatment were accounted for in the analysis. Proportion hazard assumption
was met in all the models. The region variable in the Finnish DILGOM cohort and smoking status in the Estonian Biobank cohort were set as strata in the
analysis on T2D. CHD, coronary heart disease; CVD, cardiovascular disease; DILGOM, DIetary, Lifestyle, and Genetic determinants of Obesity and
Metabolic syndrome study; T2D, type 2 diabetes.
2Frequency.
profile, making it difficult to distinguish single factors having
independent effects.
Interestingly, we observed a consistent association between
food neophobia and NMR-based metabolite ω-3 fatty acids—a
suggested objective biomarker for PUFA intake (44). Supporting
this hypothesis, we also detected a significant alteration in
PUFA intake in different levels of food neophobia, where food
neophobics had lower intakes. Moreover, the food neophobia
association with dietary quality has been reported to associate
with fish intake in particular—amajor source of dietary PUFA (6,
45). Overall, previous studies together with our findings demon-
strate potent evidence for an existing pathway between food
neophobia, dietary quality relating to fish and PUFA intake, and
circulating concentrations of serum ω-3 fatty acids. In addition,
even after adjustment for dietary quality, food neophobia was
significantly associated with higher concentrations of α1-acid
glycoprotein and citrate—biomarkers linked to inflammation,
increased mortality, and adverse disease outcomes (46). These
findings imply that dietary quality might have only a selective
role in mediating food neophobia association with the serum
metabolome profile (i.e., ω-3 fatty acids).
A growing body of large-scale metabolic profiling studies have
unveiled a number of biomarkers that are associated with health
outcomes. Circulating concentrations of ω-3 fatty acids (e.g.,
EPA, DHA, and α-linolenic acid) and HDL have been inversely
associated with a risk of CVD and all-cause mortality, whereas
MUFA, α1-acid glycoprotein, and citrate concentrations have
been associated positively with increased risk of chronic diseases
(35). Consequently, our findings on the association between food
neophobia and ω-3 fatty acids (decreased), HDL (decreased),
α1-acid glycoprotein (increased), MUFA (increased), and citrate
(increased) concentrations suggest increased risk of CVD/CHD
and T2D in individuals with high levels of food neophobia. These
findings are supported by the significant association between food
neophobia and fasting serum insulin levels together with the T2D
incidence in healthy moderate-risk individuals in the DILGOM
cohort (47, 48). Furthermore, it is well characterized that T2D
is also a major risk factor for CVD/CHD (49). To this end, an
association between food neophobia and the incidence of CHD
was detected in the Estonian Biobank cohort, reinforcing our
deduction of a plausibly increased risk of disease susceptibility,
although the detected effect sizes in both cohorts were small.
Larger longitudinal cohorts with a longer follow-up are needed to
further confirm the role of food neophobia and its associationwith
chronic disease risk. Moreover, better understanding of eating-
related behavioral traits and dietary quality association with the
serum metabolite profile is needed to more accurately predict
health outcomes. Our study generates new hypotheses suggesting
that the serum metabolome profile, especially lipids (e.g., ω-
3 fatty acids, MUFA, and HDL), α1-acid glycoprotein, and
citrate, could potentially be used as a more objective and precise
predictor in the assessment of dietary quality, dietary/lifestyle
behavior, and subsequent health outcomes if validated by future
studies.
We consider our study to have several possible limitations,
including partially self-reported anthropometric measures in
DILGOM 2014 (27) and consideration of whether the study
populations constitute a representative sample of the general
adult population. In addition, the NMR-based metabolome in
the Finnish DILGOM cohort was determined in serum but was
determined in plasma in the Estonian Biobank cohort, causing a
minor effect with regard to comparability. The fact that FNS was
gathered from the study participants in both populations during
the second study visit is also a possible limitation. However, we
believe this had only minor effects on our results, considering 1)
the stability of food neophobia as a trait during adulthood, 2) the
consistency of our results, and 3) the moderate length of our study
follow-up. We also recognize the use of a translated FNS in both
Finnish and Estonian populations as a possible limitation because
it is well acknowledged that nonequivalencies in vocabulary,
experiences, and concepts in dietary behavior in different cultures
may introduce bias. On the other hand, the strengths of the
study include 1) large study sample sizes; 2) follow-up of the
study samples regarding the NMR-based metabolome, dietary
information, and disease outcomes; 3) validity of the study
cohorts; and 4) successful partial replication of metabolome
results in a different study population with a different nationality
and cultural background.
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In conclusion, in the Finnish and Estonian adult populations, a
higher level of food neophobia was associated with lower dietary
quality, adverse concentrations of health-related biomarkers, and
a higher incidence of chronic diseases. The association of food
neophobia with a blood serum metabolomic profile seems to be
mostly mediated through dietary quality independent of body
weight and adiposity. We suggest that by identifying individuals
with higher food neophobia (e.g., in adolescence) and associated
detrimental dietary behavior and reduced dietary quality, it is
possible to prevent and reduce future risk of metabolic diseases.
Further studies are needed to verify and extend our findings and
to determine the nature of causality between food neophobia,
dietary quality, serum metabolite profile, and future disease risk
in other countries and in relation to other cultural backgrounds.
The authors’ responsibilities were as follows—KK and MP: designed the
research plan; NK, LM, JS, KB, and SM: responsible for data collection
and conducting research on the Finnish DILGOM cohort; KF, TE, and NT:
responsible for data collection and conducting research on the Estonian
Biobank cohort; HVS, NT, KF, AJ, and KK: performed statistical analysis;
HVS, KK, and MP: had primary responsibility for the final content; and all
authors: contributed to writing the manuscript and read and approved the final
manuscript. The authors report no conflicts of interest.
References
1. Knaapila A, Tuorila H, Silventoinen K, Keskitalo K, Kallela M,
Wessman M, Peltonen L, Cherkas LF, Spector TD, Perola M.
Food neophobia shows heritable variation in humans. Physiol Behav
2007;91:573–8.
2. Pliner P, Hobden K. Development of a scale to measure the trait of food
neophobia in humans. Appetite 1992;19:105–20.
3. Tuorila H, Lähteenmäki L, Pohjalainen L, Lotti L. Food neophobia
among the Finns and related responses to familiar and unfamiliar foods.
Food Qual Prefer 2001;12:29–37.
4. Dovey TM, Staples PA, Gibson EL, Halford JCG. Food neophobia and
“picky/fussy” eating in children: a review. Appetite 2008;50:181–93.
5. Törnwall O, Silventoinen K, Hiekkalinna T, Perola M, Tuorila H,
Kaprio J. Identifying flavor preference subgroups: genetic basis and
related eating behavior traits. Appetite 2014;75:1–10.
6. Knaapila A, Silventoinen K, Broms U, Rose RJ, Perola M, Kaprio J,
Tuorila HM. Food neophobia in young adults: genetic architecture and
relation to personality, pleasantness and use frequency of foods, and
body mass index—a twin study. Behav Genet 2011;41:512–21.
7. Meiselman HL, King SC, Gillette M. The demographics of neophobia
in a large commercial US sample. Food Qual Prefer 2010;21:893–7.
8. Flight I, Leppard P, Cox DN. Food neophobia and associations with
cultural diversity and socio-economic status amongst rural and urban
Australian adolescents. Appetite 2003;41:51–9.
9. Knaapila AJ, Sandell MA, Vaarno J, Hoppu U, Puolimatka T, Kaljonen
A, Lagström H. Food neophobia associates with lower dietary quality
and higher BMI in Finnish adults. Public Health Nutr 2015;18:2161–71.
10. Mozaffarian D. Dietary and policy priorities for cardiovascular
disease, diabetes, and obesity: a comprehensive review. Circulation
2016;133:187–225.
11. Kanerva N, Kaartinen NE, Schwab U, Lahti-Koski M, Männistö S.
Adherence to the Baltic Sea diet consumed in the Nordic countries is
associated with lower abdominal obesity. Br J Nutr 2013;109:520–8.
12. Kanerva N, Kaartinen NE, Rissanen H, Knekt P, Eriksson JG,
Sääksjärvi K, Sundvall J, Männistö S. Associations of the Baltic Sea
diet with cardiometabolic risk factors—ameta-analysis of three Finnish
studies. Br J Nutr 2014;112:616–26.
13. Kanerva N, Loo B-M, Eriksson JG, Leiviskä J, Kaartinen NE, Jula A,
Männistö S. Associations of the Baltic Sea diet with obesity-related
markers of inflammation. Ann Med 2014;46:90–6.
14. Calder PC, Ahluwalia N, Brouns F, Buetler T, Clement K, Cunningham
K, Esposito K, Jönsson LS, Kolb H, Lansink M, et al. Dietary factors
and low-grade inflammation in relation to overweight and obesity. Br J
Nutr 2011;106(Suppl 3):S5–78.
15. Mente A, de Koning L, Shannon HS, Anand SS. A systematic
review of the evidence supporting a causal link between dietary
factors and coronary heart disease. Arch Intern Med 2009;169:
659–69.
16. KaushikM,Mozaffarian D, Spiegelman D,Manson JE,Willett WC, Hu
FB. Long-chain omega-3 fatty acids, fish intake, and the risk of type 2
diabetes mellitus. Am J Clin Nutr 2009;90:613–20.
17. Salas-Salvadó J, Bulló M, Babio N, Martínez-González MÁ, Ibarrola-
Jurado N, Basora J, Estruch R, Covas MI, Corella D, Arós F, et al.
Reduction in the incidence of type 2 diabetes with the Mediterranean
diet: results of the PREDIMED-Reus nutrition intervention randomized
trial. Diabetes Care 2011;34:14–19.
18. Lindström J, Peltonen M, Eriksson JG, Louheranta A, Fogelholm M,
Uusitupa M, Tuomilehto J. High-fibre, low-fat diet predicts long-term
weight loss and decreased type 2 diabetes risk: the Finnish Diabetes
Prevention Study. Diabetologia 2006;49:912–20.
19. Akesson A, Andersen LF, Kristjánsdóttir AG, Roos E, Trolle E,
Voutilainen E, Wirfält E. Health effects associated with foods
characteristic of the Nordic diet: a systematic literature review. Food
Nutr Res 2013;57. doi: 10.3402/fnr.v57i0.22790.
20. Pan A, Sun Q, Bernstein AM, Manson JE, Willett WC, Hu FB.
Changes in redmeat consumption and subsequent risk of type 2 diabetes
mellitus: three cohorts of US men and women. JAMA Intern Med
2013;173:1328–35.
21. Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in diet
and lifestyle and long-term weight gain in women and men. N Engl J
Med 2011;364:2392–404.
22. Chiuve SE, Fung TT, Rimm EB, Hu FB, McCullough ML, Wang M,
Stampfer MJ, Willett WC. Alternative dietary indices both strongly
predict risk of chronic disease. J Nutr 2012;142:1009–18.
23. Sofi F, Abbate R, Gensini GF, Casini A. Accruing evidence on benefits
of adherence to the Mediterranean diet on health: an updated systematic
review and meta-analysis. Am J Clin Nutr 2010;92:1189–96.
24. Sofi F, Macchi C, Abbate R, Gensini GF, Casini A. Mediterranean
diet and health status: an updated meta-analysis and a proposal
for a literature-based adherence score. Public Health Nutr 2014;17:
2769–82.
25. Fung TT, Chiuve SE,McCulloughML, RexrodeKM, LogroscinoG,Hu
FB. Adherence to a DASH-style diet and risk of coronary heart disease
and stroke in women. Arch Intern Med 2008;168:713–20.
26. de Koning L, Chiuve SE, Fung TT, Willett WC, Rimm EB, Hu FB.
Diet-quality scores and the risk of type 2 diabetes in men. Diabetes Care
2011;34:1150–6.
27. Kanerva N, Harald K, Männistö S, Kaartinen NE, Maukonen M,
Haukkala A, Jousilahti P. Adherence to the healthy Nordic diet is
associated with weight change during 7 years of follow-up. Br J Nutr
2018;120:101–10.
28. Vartiainen E, Laatikainen T, Peltonen M, Juolevi A, Männistö S,
Sundvall J, Jousilahti P, Salomaa V, Valsta L, Puska P. Thirty-five-
year trends in cardiovascular risk factors in Finland. Int J Epidemiol
2010;39:504–18.
29. Borodulin K, Tolonen H, Jousilahti P, Jula A, Juolevi A, Koskinen S,
Kuulasmaa K, Laatikainen T, Männistö S, Peltonen M, et al. Cohort
profile: The National FINRISK study. Int J Epidemiol 2017;47:696–
696i.
30. Leitsalu L, Haller T, Esko T, Tammesoo M-L, Alavere H, Snieder H,
Perola M, Ng PC, Mägi R, Milani L, et al. Cohort profile: Estonian
Biobank of the Estonian Genome Center, University of Tartu. Int J
Epidemiol 2015;44:1137–47.
31. Ritchey PN, Frank RA, Hursti U-K, Tuorila H. Validation and cross-
national comparison of the Food Neophobia Scale (FNS) using
confirmatory factor analysis. Appetite 2003;40:163–73.
32. Reinivuo H, Hirvonen T, Ovaskainen M-L, Korhonen T, Valsta LM.
Dietary survey methodology of FINDIET 2007 with a risk assessment
perspective. Public Health Nutr 2010;13:915–9.
33. Kanerva N, Rissanen H, Knekt P, Havulinna AS, Eriksson JG,Männistö
S. The healthy Nordic diet and incidence of type 2 diabetes—10-year
follow-up. Diabetes Res Clin Pract 2014;106:e34–37.
34. Soininen P, Kangas AJ, Würtz P, Tukiainen T, Tynkkynen T,
Laatikainen R, Järvelin M-R, Kähönen M, Lehtimäki T, Viikari J, et al.
High-throughput serum NMR metabonomics for cost-effective holistic
studies on systemic metabolism. The Analyst 2009;134:1781–5.
35. Würtz P, Kangas AJ, Soininen P, Lawlor DA, Davey Smith G,
Ala-Korpela M. Quantitative serum nuclear magnetic resonance
D
ow
nloaded from
 https://academ
ic.oup.com
/ajcn/article-abstract/110/1/233/5510585 by Arts Faculty Library user on 21 O
ctober 2019
Food neophobia associates with disease outcomes 245
metabolomics in large-scale epidemiology: a primer on -omic
technologies. Am J Epidemiol 2017;186:1084–96.
36. Cooke L, Carnell S, Wardle J. Food neophobia and mealtime food
consumption in 4–5 year old children. Int J Behav Nutr Phys Act
2006;3:14.
37. Galloway AT, Lee Y, Birch LL. Predictors and consequences of
food neophobia and pickiness in young girls. J Am Diet Assoc
2003;103:692–8.
38. Cooke L, Wardle J, Gibson EL. Relationship between parental report
of food neophobia and everyday food consumption in 2–6-year-old
children. Appetite 2003;41:205–6.
39. Siegrist M, Hartmann C, Keller C. Antecedents of food neophobia and
its association with eating behavior and food choices. Food Qual Prefer
2013;30:293–8.
40. Würtz P, Wang Q, Kangas AJ, Richmond RC, Skarp J, Tiainen
M, Tynkkynen T, Soininen P, Havulinna AS, Kaakinen M, et al.
Metabolic signatures of adiposity in young adults: Mendelian
randomization analysis and effects of weight change. [internet]. PLoS
Med 2014;11(12):e1001765. Available from: https://www.ncbi.nlm.n
ih.gov/pmc/articles/PMC4260795/.
41. Zeisel SH. Nutrigenomics and metabolomics will change clinical
nutrition and public health practice: insights from studies on dietary
requirements for choline. Am J Clin Nutr 2007;86:542–8.
42. Floegel A, von Ruesten A, Drogan D, SchulzeMB, Prehn C, Adamski J,
Pischon T, Boeing H. Variation of serum metabolites related to habitual
diet: a targeted metabolomic approach in EPIC-Potsdam. Eur J Clin
Nutr 2013;67:1100–8.
43. Perry RA, Mallan KM, Koo J, Mauch CE, Daniels LA, Magarey AM.
Food neophobia and its association with diet quality and weight in
children aged 24 months: a cross sectional study. [Internet]. Int J Behav
Nutr Phys Act 2015;12:13. Available from: https://www.ncbi.nlm.nih.g
ov/pmc/articles/PMC4335451/.
44. Virtanen JK, Mursu J, Voutilainen S, Uusitupa M, Tuomainen T-P.
Serum omega-3 polyunsaturated fatty acids and risk of incident type 2
diabetes in men: the Kuopio Ischemic Heart Disease Risk Factor Study.
Diabetes Care 2014;37:189–96.
45. Helland SH, Bere E, Bjørnarå HB, Øverby NC. Food neophobia and its
association with intake of fish and other selected foods in a Norwegian
sample of toddlers: a cross-sectional study. Appetite 2017;114:
110–17.
46. Fischer K, Kettunen J, Würtz P, Haller T, Havulinna AS, Kangas AJ,
Soininen P, Esko T, TammesooM-L, Mägi R, et al. Biomarker profiling
by nuclear magnetic resonance spectroscopy for the prediction of all-
cause mortality: an observational study of 17,345 persons. PLoS Med
2014;11:e1001606.
47. Chen Y-H, Lee Y-C, Tsao Y-C, Lu M-C, Chuang H-H, Yeh W-
C, Tzeng I-S, Chen J-Y. Association between high-fasting insulin
levels and metabolic syndrome in non-diabetic middle-aged and
elderly populations: a community-based study in Taiwan. BMJ Open
2018;8:e016554.
48. Sabin MA, Magnussen CG, Juonala M, Shield JPH, Kahonen M,
Lehtimaki T, Ronnemaa T, Koskinen J, Loo B-M, KnipM, et al. Insulin
and BMI as predictors of adult type 2 diabetes mellitus. Pediatrics
2015;135:e144–51.
49. American Diabetes Association; the National Heart, Lung, and
Blood Institute; the Juvenile Diabetes Foundation International; the
National Institute of Diabetes and Digestive and Kidney Diseases;
and the American Heart Association. Diabetes mellitus: a major
risk factor for cardiovascular disease: a joint editorial statement by
the American Diabetes Association; the National Heart, Lung, and
Blood Institute; the Juvenile Diabetes Foundation International;
the National Institute of Diabetes and Digestive and Kidney
Diseases; and the American Heart Association. Circulation 1999;100:
1132–3.
D
ow
nloaded from
 https://academ
ic.oup.com
/ajcn/article-abstract/110/1/233/5510585 by Arts Faculty Library user on 21 O
ctober 2019
